Efficacy of two commercial preparations of interferon-α on human papillomavirus replication

被引:0
作者
Sen, E [1 ]
McLaughlin-Drubin, M [1 ]
Meyers, C [1 ]
机构
[1] Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA
关键词
cervical cancer; HPV; organotypic raft culture; interferon;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Previous studies on the effectiveness of interferon (IFN) therapy in the treatment of cervical carcinoma have produced highly inconsistent results and the conclusion regarding the efficacy of IFNs has been quite controversial. As the organotypic raft culture system mimics the differentiation-dependent life cycle of human papillomavirus (HPV), the causative agent of cervical cancer, we utilized the raft culture system to study the effects of interferon-alpha (IFN-alpha) on the vegetative replication of HPV. The effect of different concentrations of Interferon-alpha-n3 (Alferon N) and Interferon-alpha-2b (Intron A) on HPV16, HPV18 and HPV31b vegetative replication was studied in cell lines harboring episomal copies of these high risk HPV types. Our studies indicate that Alferon N and Intron A varied in a concentration-dependent manner in their ability to affect the viral load of different HPV types. Treatment with an increasing concentration of IFN-alpha preparations did not always correlate with a stepwise inhibition of HPV replication.
引用
收藏
页码:1091 / 1100
页数:10
相关论文
共 30 条
  • [1] ALAM S, UNPUB J GEN VIROL
  • [2] The human papillomavirus E7 protein is able to inhibit the antiviral and anti-growth functions of interferon-α
    Barnard, P
    Payne, E
    McMillan, NAJ
    [J]. VIROLOGY, 2000, 277 (02) : 411 - 419
  • [3] The human papillomavirus E7 oncoprotein abrogates signaling mediated by interferon-α
    Barnard, P
    McMillan, NAJ
    [J]. VIROLOGY, 1999, 259 (02) : 305 - 313
  • [4] AMPLIFICATION OF HUMAN PAPILLOMAVIRUS GENOMES INVITRO IS DEPENDENT ON EPITHELIAL DIFFERENTIATION
    BEDELL, MA
    HUDSON, JB
    GOLUB, TR
    TURYK, ME
    HOSKEN, M
    WILBANKS, GD
    LAIMINS, LA
    [J]. JOURNAL OF VIROLOGY, 1991, 65 (05) : 2254 - 2260
  • [5] BORNSTEIN J, 1993, OBSTET GYNECOL SURV, V48, P2151
  • [6] A NEW TYPE OF PAPILLOMAVIRUS DNA, ITS PRESENCE IN GENITAL CANCER BIOPSIES AND IN CELL-LINES DERIVED FROM CERVICAL-CANCER
    BOSHART, M
    GISSMANN, L
    IKENBERG, H
    KLEINHEINZ, A
    SCHEURLEN, W
    HAUSEN, HZ
    [J]. EMBO JOURNAL, 1984, 3 (05) : 1151 - 1157
  • [7] A PAPILLOMAVIRUS DNA FROM A CERVICAL-CARCINOMA AND ITS PREVALENCE IN CANCER BIOPSY SAMPLES FROM DIFFERENT GEOGRAPHIC REGIONS
    DURST, M
    GISSMANN, L
    IKENBERG, H
    ZURHAUSEN, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (12): : 3812 - 3815
  • [8] In vitro synthesis of oncogenic human papillomaviruses requires episomal genomes for differentiation-dependent late expression
    Frattini, MG
    Lim, HB
    Laimins, LA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (07) : 3062 - 3067
  • [9] FRAZER IH, 1997, CLIN APPL INTERFERON, P79
  • [10] Therapy of human papillomavirus infection and associated epithelial tumors
    Gross, G
    [J]. INTERVIROLOGY, 1997, 40 (5-6) : 368 - 377